Drug Type Biological products |
Synonyms anti-IL-13RA2/EphA2 radiopharmaceutical (WPD Pharmaceuticals) |
Target |
Mechanism EphA2 modulators(Ephrin type-A receptor 2 modulators), IL-13Rα2 modulators(Interleukin-13 receptor subunit alpha-2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | PL | - |